Press Releases

 Filter by Provider

K1x, the tax data operations solution for private markets, today announced a strategic partnership with Juno, a modern tax preparation, review, and advisory platform built by CPAs for the realities of practice life. The partnership introduces a new integration that enables automated K-1 data to flow directly into Juno, powered by patented K1x technology.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced updates on its research and development programs and highlighted upcoming key milestones for 2026.

Virometix AG, a clinical-stage biotechnology company pioneering fully synthetic vaccines, today announced positive topline data from the Company’s Phase 1 trial of its lead asset V-212, a serotype-independent pneumococcal vaccine candidate, in development for the prevention of pneumococcal disease caused by Streptococcus pneumoniae (Spn) infections. The study evaluated safety and immunogenicity in healthy volunteers, with data demonstrating an excellent safety profile and robust immune responses across all three target antigens in the vaccine.

Hobbyists and Small Businesses Must Navigate FAA Rules, Local Ordinances, and Privacy Concerns

SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced that the first patient has been dosed in the Part B dose-expansion portion of the Phase 1/2 ASTRA clinical trial of SB-007, a dual adeno-associated viral (AAV) vector gene therapy for the treatment of Stargardt disease.

Concord, an H.I.G. Capital portfolio company and leading provider of technology and digital transformation solutions, today announced the appointment of Chris Baker as Executive Chairman.

TD SYNNEX (NYSE: SNX) today announced financial results for the fiscal fourth quarter ended November 30, 2025.

RICHMOND, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Indivior PLC (Nasdaq: INDV) (“Indivior PLC” or the “Company”) today announced its full-year 2026 financial guidance.

Striveworks, a leading developer of cutting-edge artificial intelligence solutions, has been selected to provide AI test and evaluation services for the U.S. Army under a Phase II Small Business Innovation Research (SBIR) award. Striveworks’ AI operations (AIOps) platform will standardize and scale the test and evaluation of AI models. This is a critical step in deploying secure and reliable AI capabilities aligned with Army modernization priorities.

AstraZeneca has named Rick R. Suarez Senior Vice President, US President and Head of the US BioPharmaceuticals Business Unit.

Initial study will enable further collaboration on the predictive capabilities of StemPrintER

State of Crypto Perpetual Swaps 2025 details market stress, trust gaps and new derivatives trends

CMR Surgical receives CE Mark for use of Versius in paediatric surgery

BEDFORD, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that Stephen (Steve) Griffin, current Executive Vice President, Chief Financial Officer and Chief Operating Officer, has been appointed President and Chief Executive Officer and a member of the Board of Directors, effective February 1, 2026. Mr. Griffin will succeed Cheryl R. Blanchard, Ph.D., who will become Executive Chair of the Board of Directors. In addition, John (Jack) B. Henneman, III, Director since 2020, has been appointed Lead Independent Director.

Data readouts planned for CLN-978 across all three autoimmune indications in 2026, including single dose and repeat dosing data

Phase 3 Topline Results for Potential Best-in-Class Regimen for Treatment of HCV on Track for 2026

-- Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 –

Vancouver, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to report results from its 2025 multidisciplinary drilling and field program at the 100%-owned Berg Project in central British Columbia. The program was designed to advance Berg toward completion of a Pre-Feasibility Study (“PFS”) planned for H1-2026 (see November 19, 2025 press release), and was successfully executed with a focus on resource category conversion, validation of historic drilling through modern QA/QC procedures, acid rock drainage characterization, and geotechnical investigations for planned mine infrastructure.

SAN MATEO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that it will be presenting a poster at the upcoming 10th Annual MASH-TAG Conference being held January 8-10, 2026 in Park City, Utah. The poster will focus on the observed anti-fibrotic effects in F3 and qFibrosis stage 4 MASH patients in the Phase 2b FASCINATE-2 clinical trial of fatty acid synthase (FASN) inhibitor denifanstat.

MONTREAL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) is very pleased to announce a maiden, open-pit Mineral Inferred Resource Estimate (“MRE”) of 52.2 million tonnes (“Mt”) grading 1.08% Li2O and 131ppm Ta2O5 for its wholly owned Mirage Project located in the Eeyou Istchee Baie-James region of Quebec, Canada (see Figure 1). The MRE was prepared in accordance with the National Instrument (“NI”) 43-101 standards by PLR Resource Inc. and Synectiq Inc.

MONTREAL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Troilus Mining Corp. (TSX: TLG; OTCQX: CHXMF; FRA: CM5) (“Troilus” or the “Company”), is pleased to provide a review of its key accomplishments in 2025 and an outlook for 2026, as the Company advances its flagship Troilus copper-gold project (the “Project”) through critical development milestones and positions it for the next phase of execution, in this open letter to shareholders from Chief Executive Officer, Justin Reid. To our valued shareholders and stakeholders,

TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Kinross Gold Corporation (TSX: K; NYSE: KGC) (“Kinross”) will provide an update on its Round Mountain Phase X, Kettle River-Curlew and Bald Mountain Redbird 2 projects, followed by a virtual presentation and question and answer session at 9:00 a.m. EST on Thursday, January 15, 2026.

Dr. Duda to apply deep expertise in rare and immune-mediated diseases

LONDON and MILAN, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026 in San Francisco, California.

America’s largest pet grooming brand reports 25% YoY sales increase; doubles its footprint in three years

The agreement converts certain legacy assets into a structured payment obligation supported by collateral and a personal guaranty, while expressly excluding intellectual property related to the ‘Of Kos’ brand from the sale. The transaction closed December 31, 2025 and became effective as of December 30, 2025

SHENZHEN, China, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today extended its congratulations to Knowledge Atlas Technology Joint Stock Company Limited, also known as Zhipu, on its successful listing on the Main Board of the Stock Exchange of Hong Kong.

First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 

LONDON and CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and restore vision in people with rare and prevalent ocular diseases, today announced that it has raised over $75 million in an oversubscribed Series C financing led by Life Sciences at Goldman Sachs Alternatives and with participation from the Retinal Degeneration Fund (RD Fund), the venture arm of Foundation Fighting Blindness. Beacon’s existing investors, Syncona Limited, Forbion, Oxford Science Enterprises, and Advent Life Sciences, also participated in the round.

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc (NASDAQ: ATAI) (“AtaiBeckley” or the “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments, today provided its outlook for 2026 ahead of attendance at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco, California, on January 12 – 15, 2026.

U.S. IPE Market Leadership Sustained; $70M Restructuring OPEX Savings on Pace for Mid-2026; Completed Transition to Fully Partnered Model Across All International Markets

Company Expects to Report Topline Data in Q4 2026

DENVER, CO / ACCESS Newswire / January 8, 2026 / Today, Clough Global Opportunities Fund (NYSE American:GLO) (the "Fund") declared monthly cash distributions of $0.0537 per common share, payable on the dates noted below. These distributions represent a 7.2% increase from the Fund's prior distributions and are made under the Fund's managed distribution policy, which is intended to provide shareholders with a consistent monthly distribution at a rate of at least one-twelfth of 10% of the Fund's average net asset value ("NAV") per share for the last five business days of the prior calendar year.

DENVER, CO / ACCESS Newswire / January 8, 2026 / Today, Clough Global Equity Fund (NYSE American:GLQ) (the "Fund") declared monthly cash distributions of $0.0729 per common share, payable on the dates noted below. These distributions represent a 12.2% increase from the Fund's prior distributions and are made under the Fund's managed distribution policy, which is intended to provide shareholders with a consistent monthly distribution at a rate of at least one-twelfth of 10% of the Fund's average net asset value ("NAV") per share for the last five business days of the prior calendar year.

DENVER, CO / ACCESS Newswire / January 8, 2026 / Today, Clough Global Dividend and Income Fund (NYSE American:GLV) (the "Fund") declared a monthly cash distribution of $0.0566 per common share, payable on the dates noted below. These distributions represent a 7.6% increase from the Fund's prior distributions and are made under the Fund's managed distribution policy, which is intended to provide shareholders with a consistent monthly distribution at a rate of at least one-twelfth of 10% of the Fund's average net asset value ("NAV") per share for the last five business days of the prior calendar year.

BuffBuff is changing how players understand digital purchases, especially as video gaming grows more connected and more global. In the past, players often felt confused when buying in-game currency. Prices changed quickly, and rules were unclear. However, reliable third-party platforms have slowly improved this experience. Because of better systems and clearer rules, players now feel safer and more informed before spending money.

First Foundation Inc. (NYSE: FFWM) (“First Foundation”), a financial services company with two wholly owned operating subsidiaries, First Foundation Advisors and First Foundation Bank, announced today that it will release its fourth quarter 2025 earnings results before the market opens on Thursday, January 29, 2026.

The Buckle, Inc. (NYSE: BKE) announced today that comparable store net sales, for stores open at least one year, for the 5-week period ended January 3, 2026 increased 5.5 percent from comparable store net sales for the 5-week period ended January 4, 2025. Net sales for the 5-week fiscal month ended January 3, 2026 increased 6.5 percent to $215.3 million from net sales of $202.1 million for the prior year 5-week fiscal month ended January 4, 2025.

The NAR REALTOR Benefits® Customer Experience Award celebrates RentRedi’s impact on real estate agents who advise rental investors and operate their own rental businesses

RPM International Inc. (NYSE: RPM), a world leader in specialty coatings, sealants and building materials, today reported financial results for its fiscal 2026 second quarter ended November 30, 2025.

Helen of Troy Limited (NASDAQ: HELE), designer, developer, and worldwide marketer of branded consumer home, outdoor, beauty, and wellness products, today reported results for the three-month period ended November 30, 2025.

Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today announced results for its first quarter of fiscal 2026, which ended on November 30, 2025.

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. today announced it will host its fourth quarter and full year 2025 conference call and webcast on Wednesday, February 4, 2026, at 10:00 a.m. ET.

DAYTONA BEACH, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE:BRO), and Jack Brubaker and L. Allan Boyd, owners of Shoemaker & Besser Associates, Inc. (“Shoemaker & Besser”), today announced that a Bridge Specialty Group company and subsidiary of Brown & Brown, Inc. has acquired the assets of Shoemaker & Besser.

In two separate rulings secured by eDreams ODIGEO (hereinafter, ‘eDO'), the German Court not only penalised Ryanair for its disobedience to court orders but also declared several of the airline's core commercial practices unlawful.